Our understanding of the neurobiology of psychiatric disorders remains limited, and biomarker-based clinical management is yet to be developed. Induced pluripotent stem cell (iPSC) technology has revolutionized our capacity to generate patient-derived neurons to model psychiatric disorders. Here, we highlight advantages and caveats of iPSC disease modeling and outline strategies for addressing current challenges.
No takes yet. Share an insight, caveat, or question.
Vadodaria et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: